Stryker

Internship Software for AI Applications in Robotic-Assisted Surgery – 6 Months | Start Spring 2027

Stryker
Apply
2 months ago
Freiburg im Breisgau, GermanyIntern

Responsibilities

  • Develop software components using C++ and Linux technologies.
  • Support AI-driven software solutions for robotic-assisted surgery.
  • Apply computer vision, image processing, and machine learning techniques to healthcare challenges.
  • Evaluate algorithm performance and contribute to technical improvements.
  • Collaborate with software engineers, biomedical engineers, and domain experts in multidisciplinary teams.

Requirements

  • Currently pursuing a master’s degree in computer science, biomedical engineering, medical engineering, software engineering, information technology, or a related field.
  • Initial experience with C++ and Python.
  • Basic knowledge of AI foundations, computer vision, or robotics.
  • Interest in healthcare software, medical imaging, and innovative technologies.
  • Good English language skills at a minimum B2 level.
  • Application materials must include a short cover letter, current CV/resume, and transcript of records.

Benefits

  • Paid six-month full-time internship, with voluntary, mandatory, or combined internship arrangements possible.
  • Start date in March or April 2027.
  • Location in Freiburg, Germany; work flexibility is not available.
  • Flexible working hours and an attractive holiday allowance.
  • Mentoring and training in an international environment.
  • Hands-on projects with real-world healthcare impact.

Tech Stack

C++LinuxPythonRobot Framework

Categories

Robotics
Stryker

About Stryker

10,000+ employees

Stryker designs and manufactures medical devices and equipment for hospitals and surgeons, spanning orthopaedic implants, trauma and spine hardware, surgical tools, endoscopy, navigation, and patient care equipment. The NYSE-listed company, founded in 1941 and headquartered in Kalamazoo, Michigan, sells products and related services worldwide to health systems and ambulatory centers. It reported $22.6 billion in 2024 sales and markets its portfolio across roughly 75 countries.

Contact me